Danapha Asterisk NOZ nasal spray 0.1% 15ml No. 1
Short review
Selected in the rating
7
Best rating
drugs for the common cold
For adults - For children - For nasal congestion - Sprays
Buy Danapha Asterisk NOZ nasal spray 0.1% 15ml No. 1
Characteristics Danapha Asterisk NOZ nasal spray 0.1% 15ml No. 1
Yandex.Market data
General characteristics | |
Drug type | medicinal product |
Release form | spray |
Minimum age of use | from 6 years |
Appointment | from a cold |
Additionally | |
Indications for use | - acute allergic rhinitis; - acute respiratory infections with symptoms of rhinitis; - sinusitis; - hay fever; - otitis media (to reduce swelling of the nasopharyngeal mucosa); - preparation of the patient for diagnostic manipulations in the nasal passages. |
Contraindications | - arterial hypertension; - tachycardia; - severe atherosclerosis; - glaucoma; - atrophic rhinitis; - thyrotoxicosis; - Surgical interventions on the meninges (in history); - pregnancy; - children's age (up to 6 years old); - hypersensitivity to drug components. With care: lactation, coronary artery disease (angina pectoris), prostatic hyperplasia, diabetes mellitus. |
Application during pregnancy and lactation | Contraindicated. |
Influence on the ability to drive vehicles and mechanisms | Not described. |
Active substance | Xylometazoline |
Method of administration and dosage | Intranasally. Adults and children over 6 years old: 2-3 drops in each nasal passage 2-3 times / day. Do not use more than 3 times / day |
Side effects | When applied, it can cause a burning sensation in the nose and throat, local irritation, paresthesia, sneezing, hypersecretion, dryness of the nasal mucosa. Allergic reactions are possible. Rarely - swelling of the nasal mucosa, palpitations, tachycardia, arrhythmias, increased blood pressure, headache, nausea, vomiting, insomnia, visual impairment; depression (with prolonged use in high doses). If symptoms occur, stop using the drug and consult a doctor. |
Storage conditions | Store the drug at a temperature of 15 ° C to 25 ° C. Keep out of the reach of children. Shelf life 3 years. Do not use after the expiration date printed on the package. |
Overdose | Symptoms: in case of accidental poisoning with xylometazoline, when taken orally, mydriasis, nausea, vomiting, cyanosis, fever, spasms, tachycardia, cardiac arrhythmia, collapse, cardiac arrest, hypertension, pulmonary edema, respiratory disorders, mental disorders, suppression of the central nervous system function, accompanied by , a decrease in body temperature, bradycardia, hypotension, apnea, coma. Treatment: gastric lavage, the appointment of activated carbon, if necessary, mechanical ventilation. To lower blood pressure - phentolamine IV slowly at a dose of 5 mg or orally at a dose of 100 mg. Vasopressor agents are contraindicated. If necessary, antipyretic and anticonvulsants are used. |
special instructions | Frequent and prolonged use is not recommended for chronic diseases of the nasopharynx. For colds in cases where crusts form in the nose, it is preferable to prescribe in the form of a gel. |
Interaction | Do not use simultaneously with MAO inhibitors and tricyclic antidepressants. |
pharmachologic effect | Alpha adrenostimulant. It narrows the blood vessels of the nasal mucosa, eliminating edema and hyperemia of the mucous membrane. Facilitates nasal breathing with rhinitis. The action begins in a few minutes and lasts for several hours. |
Pharmacological group | Decongestant - vasoconstrictor (alpha adrenergic agonist) |
Structure | 1 ml: xylometazoline hydrochloride - 1 mg. |
Registration number | LSR-009582/09 |
Date of state registration | 30.08.2017 |
Reviews about Danapha Asterisk NOZ nasal spray 0.1% 15ml No. 1
Yandex.Market data
Advantages: Good spray Price: 71 rubles Disadvantages: Not found
June 6, 2019
The best nasal drops!
19 october 2018
The best drops!
25 february 2018
Advantages: Sucks a lot Good helps
7 February 2015
Pluses: Good for application, nose pierce easily. I used it cool and the norms are now without snot
11 July 2014
Excellent drops
May 27, 2014